Re: Cursiefen et al.: Aganirsen antisense oligonucleotide eye drops inhibit keratitis-induced corneal neovascularization and reduce need for transplantation: the I-CAN study (Ophthalmology 2014;121:1683-92).
Department of Ophthalmology, School of Medicine at Ribeirao Preto, University of São Paulo, São Paulo, Brazil. Electronic address: emrocha@fmrp.usp.br.
Eduardo M
EM
Rocha
Department of Ophthalmology, School of Medicine at Ribeirao Preto, University of São Paulo, São Paulo, Brazil.
Luis Fernando
LF
Nominato
Department of Ophthalmology, School of Medicine at Ribeirao Preto, University of São Paulo, São Paulo, Brazil.
Peter S
PS
Reinach
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D016510:Corneal Neovascularization / Q000188:drug therapy*; D016039:Corneal Transplantation; D005260:Female; D006801:Humans; D007634:Keratitis / Q000150:complications*; D008297:Male; D009841:Oligonucleotides / Q000627:therapeutic use*; D016376:Oligonucleotides, Antisense / Q000627:therapeutic use*
D020533:Angiogenesis Inhibitors; D009841:Oligonucleotides; D016376:Oligonucleotides, Antisense